4,439 results match your criteria: "Centre Hospitalier Lyon-sud[Affiliation]"
Gynecol Oncol
October 2024
Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.
Front Pharmacol
July 2024
Division of Clinical Pharmacology, Amiens University Hospital, Amiens, France.
Eur J Dermatol
June 2024
Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'Allergologie et Immunologie Clinique, Pierre Bénite cedex, F-96495, France, CIRI - Centre International de Recherche en Infectiologie (Team Epidermal Immunity and Allergy), Inserm U1111, CNRS UMR 5308, ENS de Lyon, Lyon.
Eur J Dermatol
June 2024
Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Cell Death Discov
July 2024
CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.
Front Vet Sci
June 2024
Intensive Care Unit (SIAMU), Université de Lyon, VetAgro Sup, Marcy l'Etoile, France.
Introduction: Motor vehicular trauma, bite wounds, high-rise syndrome, and trauma of unknown origin are common reasons cats present to the emergency service. In small animals, thoracic injuries are often associated with trauma. The objective of this retrospective study was to evaluate limits of agreement (LOA) between thoracic point-of-care ultrasound (thoracic POCUS) and thoracic radiography (TXR), and to correlate thoracic POCUS findings to animal trauma triage (ATT) scores and subscores in a population of cats suffering from recent trauma.
View Article and Find Full Text PDFThe objective of the study was the analysis of clinical types, outcomes, and risk factors associated with the outcome of adenovirus (ADV) infection, in children and adults after allo-HCT. A total number of 2529 patients (43.9% children; 56.
View Article and Find Full Text PDFPract Radiat Oncol
November 2024
Department of Radiation Oncology, Institut Bergonié, Bordeaux, France.
Purpose: The occurrence of genitourinary (GU) toxicity is a common adverse event observed after external beam radiation therapy (EBRT) for prostate cancer (PCa). Recent findings suggest that the dose delivered to specific urinary organs at risk (OARs) such as the ureters, bladder trigone, and urethra is involved in the development of GU toxicity.
Methods And Materials: A multidisciplinary task force including 3 radiation oncologists, a uroradiologist, and a urologist was created in 2022.
J Allergy Clin Immunol
November 2024
Hospices Civils de Lyon, Lyon, France; Centre de Références Maladies Rares, Rhumatismes inflammatoires et les maladies Auto-Immunes Systémiques rares de l'Enfant (RAISE), Lyon, France; Centre International de Recherche en Infectiologie (CIRI), Institut National de la Santé et de la Recherche Médicale (INSERM) U1111, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon, Lyon, France; Department of Pediatrics Nephrology, Rheumatology, and Dermatology, Hôpital Femme-Mère-Enfant, Bron, France. Electronic address:
Eur Ann Otorhinolaryngol Head Neck Dis
November 2024
Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Oncoimmunology
June 2024
Cancer Research Center of Lyon, INSERM 1052 - CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
The need for reliable biomarkers to predict clinical benefit from anti-PD1 treatment in metastatic melanoma (MM) patients remains unmet. Several parameters have been considered in the tumor environment or the blood, but none has yet achieved sufficient accuracy for routine clinical practice. Whole blood samples from MM patients receiving second-line anti-PD1 treatment (NCT02626065), collected longitudinally, were analyzed by flow cytometry to assess the immune cell subsets absolute numbers, the expression of immune checkpoints or ligands on T cells and the functionality of innate immune cells and T cells.
View Article and Find Full Text PDFGenes (Basel)
May 2024
Unité Pathologies Métaboliques, Érythrocytaires et Dépistage Périnatal, Service de Biochimie et Biologie Moléculaire, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 69500 Bron, France.
Hereditary sensory and autonomic neuropathy type 1 is an autosomal dominant neuropathy caused by the or variants. These variants modify the preferred substrate of serine palmitoyl transferase, responsible for the first step of sphingolipids synthesis, leading to accumulation of cytotoxic deoxysphingolipids. Diagnosis of HSAN1 is based on clinical symptoms, mainly progressive loss of distal sensory keep, and genetic analysis.
View Article and Find Full Text PDFJ Imaging Inform Med
December 2024
Université de Lyon, Université Lyon 1, 69003, Lyon, France.
The gold standard for otosclerosis diagnosis, aside from surgery, is high-resolution temporal bone computed tomography (TBCT), but it can be compromised by the small size of the lesions. Many artificial intelligence (AI) algorithms exist, but they are not yet used in daily practice for otosclerosis diagnosis. The aim was to evaluate the diagnostic performance of AI in the detection of otosclerosis.
View Article and Find Full Text PDFRev Mal Respir
September 2024
Centre Hospitalier Lyon Sud, CRCM adulte de Lyon, Pierre-Bénite, France; Research on Healthcare Performance (RESHAPE), Inserm U1290, Lyon, France.
Introduction: Chest-physiotherapy is a key element in treatment of cystic fibrosis and patient adherence is a major issue in global cystic fibrosis care. This study aims to assess adherence to chest physiotherapy in adults with cystic fibrosis who not treated with tritherapy and to analyze the impact of certain factors on adherence.
Methods: Thus is a cross-sectional study, conducted using a questionnaire and a physiotherapy evaluation.
Dermatol Ther (Heidelb)
July 2024
Department of Dermatology, Centro Hospitalar Universitario de Santo António, ICBAS, University of Porto, Porto, Portugal.
Eur Arch Otorhinolaryngol
October 2024
Service ORL, Chirurgie Cervico-Maxillo-Faciale et Audiophonologie, Centre Hospitalier Universitaire de Poitiers, Poitiers, 86000, France.
Purpose: Peri-operative management of nasal cerebrospinal fluid (CSF) leaks is not consensual due to limited evidence. The main aim of this study was to identify key factors in peri-operative management of endoscopic endonasal CSF leak repair among international experts.
Methods: A 60-item survey questionnaire collected opinions of members of international learned societies of ENT surgeons and neurosurgeons on nasal packing, post-operative instructions, antibiotic prophylaxis, and CSF volume depletion.
Int J Radiat Oncol Biol Phys
November 2024
Hôpital Tenon, APHP, Radiation Oncology Department, Sorbonne University, Paris, France.
Purpose: The influence of human immunodeficiency virus (HIV) infection on clinical outcomes in patients receiving (chemo)radiation therapy (RT) for squamous cell carcinoma of the anus (SCCA) is debated. The objective of this study was to compare efficacy and safety according to HIV status in patients with SCCA treated with C/RT.
Methods And Materials: Between January 2015 and April 2020, 488 patients with a known HIV status (17.
Eur J Dermatol
April 2024
Department of Allergology and Immunology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
Diabetes Obes Metab
November 2024
Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Clin Chem Lab Med
November 2024
Oncopharmacology Laboratory, Centre Antoine Lacassagne, Nice, France.
Objectives: Dihydropyrimidine dehydrogenase (DPD) deficiency is the main cause of severe fluoropyrimidine-related toxicities. The best strategy for identifying DPD-deficient patients is still not defined. The EMA recommends targeted genotyping or uracilemia (U) testing.
View Article and Find Full Text PDFLancet Oncol
August 2024
Department of Hematology, EMN/Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Background: CASSIOPEIA part 1 demonstrated superior depth of response and prolonged progression-free survival with daratumumab in combination with bortezomib, thalidomide, and dexamethasone (D-VTd) versus bortezomib, thalidomide, and dexamethasone (VTd) alone as an induction and consolidation regimen in transplant-eligible patients newly diagnosed with myeloma. In CASSIOPEIA part 2, daratumumab maintenance significantly improved progression-free survival and increased minimal residual disease (MRD)-negativity rates versus observation. Here, we report long-term study outcomes of CASSIOPEIA.
View Article and Find Full Text PDFAm J Clin Dermatol
July 2024
Pfizer Inc., Collegeville, PA, USA.
Background: Abrocitinib, an oral, once-daily, Janus kinase 1-selective inhibitor, is efficacious in moderate-to-severe atopic dermatitis with a manageable long-term safety profile.
Objective: We aimed to provide updated integrated long-term safety results for abrocitinib from available data accrued up to a maximum of almost 4 years in patients with moderate-to-severe atopic dermatitis from the JADE clinical development program.
Methods: Analysis included 3802 patients (exposure: 5213.
Biomark Med
August 2024
EA UCBL/HCL 3738, Centre pour l'lnnovation en Cancérologie de Lyon (CICLY), Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, Oullins-Pierre-Bénite, 69921, France.
Eur J Surg Oncol
September 2024
Department of Surgical Oncology, Centre Hospitalier Lyon Sud, Pierre Bénite, France.
Background: Despite modern systemic chemotherapy, survival remains poor for patients with advanced isolated peritoneal metastases from the gastrointestinal tract. We aimed to assess the safety and efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with oxaliplatin.
Patients And Methods: We conducted a phase 1/2, open label, non-comparative, dose escalation and expansion trial of PIPAC with oxaliplatin in patients with a peritoneal cancer index (PCI) of more than 5, 13 and 15 for respectively a gastric, small bowel and colorectal primary cancer, and who had received at least three months of systemic chemotherapy.
Inflamm Bowel Dis
June 2024
Department of Digestive Surgery, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, France.